SlideShare a Scribd company logo
Michael Ingram, MD
 Introduction to Obsessive Compulsive and Related Disorders
 Epidemiology of OCD
 Diagnosis of OCD
 Neurobiology of Impulsivity and Compulsivity
 Treatment
 Prognosis
 Brief tour of the other OCD spectrum disorders
At the conclusion of this lecture, you should be able:
 To recognize the signs and symptoms of OCD and related disorders
 To review the basic neurobiology of impulsivity and compulsivity
 To recall the available treatment options for OCD and related disorders
 What is an obsession?
 A recurrent and intrusive thought, feeling, idea, or sensation
 An obsession is a mental event
 What is a compulsion?
 A compulsion is a conscious, standardized, recurrent behavior, such
as counting, checking, or avoiding
 A compulsion is a behavior
 In OCD, obsessions and compulsions are ego-dystonic
 Compulsive acts are carried out in an attempt to relieve the
anxiety associated with the obsession
 Sometimes it works, sometimes it doesn’t work
 Resisting a compulsive act increases anxiety
 Epidemiology
 2-3% lifetime prevalence in general population
 4th most common outpatient psychiatric diagnosis
 10% of outpatients in psychiatric clinics
 Epidemiological studies in Europe, Asia, and Africa have confirmed
these rates across cultural boundaries
 Estimated that 40% of patients do not achieve a clinical response
from SSRIs1
 Epidemiology (Continued…)
 Females slightly more than males in adulthood
 Boys 2-3 times more affected than girls in childhood
 Mean onset 19.5 years old, rarely onset after 35
 Males earlier age of onset than females
 Mean age of onset: 20 years
 Boys: 19 years (mean)
 Girls: 22 years (mean)
 ~60% have onset of symptoms before 25yo
 <15% have onset of symptoms after 35yo
 Single persons > Married persons
 Possible Risk Factors
 Genetic factors (monozygotic concordance rate of 0.57)
 Environmental factors (trauma, abuse, perinatal, infectious)
 Psychosocial and developmental factors
 Controversy
 Childhood streptococcal infections increase risk of OCD (PANDAS)?
 Associated conditions
 90% of patients with OCD have psychiatric comorbidities
 76% Anxiety disorders
 63% Mood disorders
 56% Impulse control disorders
 39% Substance use disorders
 30% of patients with OCD have accompanying tic disorder
 OCD in children and adolescents
 Comorbidities reported in up to 50% pediatric patients
 ADHD
 Separation anxiety disorder
 Specific phobias
 Anxiety disorders
 Tourette disorder
 DSM-5 Criteria
A. Presence of obsession, compulsions, or both
 Obsessions are defined by 1 and 2
1. Recurrent and persistent thoughts, urges, or images that are
experienced, at some time during the disturbance, as intrusive and
unwanted, and that cause marked anxiety or distress
2. The individual attempts to ignore or suppress such thoughts, urges,
or images, or to neutralize them with some other thought or action (ie.,
by performing a compulsion)
 DSM-5 Criteria
A. Presence of obsessions, compulsions, or both
 Compulsions are defined by 1 and 2
1. Repetitive behaviors or mental acts that the individual feels driven
to perform in response to an obsession or according to rules that must
be applied rigidly
2. The behaviors or mental acts are aimed at preventing or reducing
anxiety or distress, or preventing some dreaded event or situation;
however, these behaviors or mental acts are not connected in a realistic
way with what they are designed to neutralize or prevent, or are
clearly excessive
 DSM-5 Criteria
B. The obsessions or compulsions are time-consuming (e.g., take more
than 1 hour per day) or cause clinically significant distress or
impairment in social, occupational, or other important areas of
functioning
C. Symptoms are not attributable to the physiological effects of a
substance or another medication
D. The disturbance is not better explained by symptoms of another
mental disorder (e.g., GAD, hoarding do, trichotillomania do, excoriation
do, eating do, etc)
Specifiers
 Insight: good, fair, poor, absent, delusional
 Tic-related: The individual has a current or past history of a tic disorder
Contamination
(hand washing,
cleaning)
Symmetry/Precision
(Slowness)
Intrusive Thoughts
Pathological
Doubt
(Checking)
There is considerable overlap, but generally patients present with a
predominant symptom pattern of an obsession-compulsion pair.
Compulsions in parenthesis
YBOCS is often used in clinical research in an attempt to
quantify OCD symptom severity and track progress over time
Pauls, David L., Amitai Abramovitch, Scott L. Rauch,
and Daniel A. Geller. "Obsessive–compulsive Disorder:
An Integrative Genetic and Neurobiological
Perspective." Nature Reviews Neuroscience Nat Rev
Neurosci (2014): 410-24. Print.
 Neurotransmitters implicated in OCD pathophysiology
 Serotonin – supported by alleviation of symptoms with SSRIs
 Glutamate – glutamate modulating drugs showing promising results
 Dopamine
 Cortico-striato-thalamo-cortical circuit (CSTC)
 Hyperactivity in orbitofrontal cortex (OFC), anterior cingulate cortex
(ACC), and caudate nucleus
 Glutamate is the primary excitatory neurotransmitter in CSTC
 Increased Glutamate levels in CSF, caudate, and OFC in OCD pts
Circuitry of impulsivity and reward. The
“bottom-up” circuit that drives impulsivity
(shown in pink) is a loop with projections from
the ventral striatum to the thalamus, from the
thalamus to the ventromedial prefrontal cortex
(VMPFC), and from the VMPFC back to the
ventral striatum. This circuit is usually
modulated “top-down” from the prefrontal
cortex (PFC). If this top-down response
inhibition system is inadequate or is overcome
by activity from the bottom-up ventral
striatum, impulsive behaviors may result.
Circuitry of compulsivity and motor response
inhibition. The “bottom-up” circuit that drives
compulsivity (shown in pink) is a loop with
projections from the dorsal striatum to the
thalamus, from the thalamus to the orbitofrontal
cortex (OFC), and from the OFC back to the dorsal
striatum. This habit circuit can be modulated “top-
down” from the OFC, but if this top-down response
inhibition system is inadequate or is overcome by
activity from the bottom-up dorsal striatum,
compulsive behaviors may result.
Stahl’s Essential Psychopharmacology 4th ed
 Etiology & Pathophysiology – remains unclear
 Heterogeneous
 Biological Factors
 Genetic polymorphisms
 Autoimmune processes
 Infection
 Inflammatory and oxidative stress
 Abnormalities of neurotransmission
 Behavioral Factors
 Psychosocial Factors
Pauls, David L., Amitai Abramovitch, Scott L. Rauch,
and Daniel A. Geller. "Obsessive–compulsive Disorder:
An Integrative Genetic and Neurobiological
Perspective." Nature Reviews Neuroscience Nat Rev
Neurosci (2014): 410-24. Print.
Pauls, David L., Amitai Abramovitch, Scott L. Rauch,
and Daniel A. Geller. "Obsessive–compulsive Disorder:
An Integrative Genetic and Neurobiological
Perspective." Nature Reviews Neuroscience Nat Rev
Neurosci (2014): 410-24. Print.
 Current Treatment (pharmacotherapy + behavioral)
 SSRIs (typically requires higher doses compared to depression)
 Fluoxetine
 Fluvoxamine
 Paroxetine
 Sertraline
 Citalopram
 Clomipramine
 TCA most selective for serotonin reuptake
 Other therapies
 ECT
 Surgery (Psychosurgery)
 Deep Brain Stimulation
 Glutamatergic agents
 Problems with current treatment
 Only 20-30% of patients have significant improvement
 40-50% of patients have moderate improvement
 20-40% of patients do not respond or get worse!
 Higher doses of SSRIs required to alleviate symptoms in OCD
 Associated adverse effects lead to patient non-compliance
• Obsessive-Compulsive or Related Disorder Due to another medical condition
• PANDAS
• Substance induced Obsessive-Compulsive or related disorder
• Olfactory Reference Syndrome
• Body Dysmorphic Disorder
• Hoarding Disorder
• Hair-Pulling Disorder (Trichotillomania)
• Excoriation (Skin-Picking) Disorder
Hypothesis: Acute and rapid onset of
OCD/Tics symptoms in a subset of children
with group A beta hemolytic streptococcal
infections.
Antibodies to GABHS cross react with
basal ganglia neurons causing dysfunction
Controversial
https://www.healthynewbornnetwork.org/blog/have-
you-got-data-on-follow-up-of-children-after-group-b-
streptococcus-infection/
 A false belief by the patient that he or she has a foul body odor
that is not perceived by others
 Leads to excessive showering, changing clothes
 May rise to level of somatic delusion
 (Delusional Disorder)
 Rule out organic illness
 Temporal lobe epilepsy
 Pituitary tumors
 Sinusitis
 Preoccupation with an imagined defect in appearance that causes clinically significant distress
 If a slight physical anomaly is actually present, the person’s concern with the anomaly is excessive and
bothersome
 Compulsions:
 Mirror checking
 Excessive grooming
 Comparing appearance to others
 Men: preoccupation with muscle mass and “bulking up”
 Women>Men; unmarried; AoO = 15-30years
 High comorbidity with MDD, Anxiety, Psychosis
 Body dysmorphic Disorder more often seen in
 Plastic Surgery Clinics
 Dermatology Clinics
 Internist/Primary Care Clinics
 Treatments
 Fluoxetine
 Clomipramine
 TCAs
 MAOIs
 Psychotherapy
 Surgical/procedural interventions rarely benefit these patients
https://en.wikipedia.org/wiki/Body_dysmorp
hic_disorder
 Acquiring and not discarding unimportant possessions
of little or no value
 Obsessive fear of losing important items that may be
needed in the future
 Distorted beliefs about the importance of possessions
 Excessive emotional attachment to possessions
 Leads to
 Cluttering
 Unsanitary living conditions
 Health risks (falls, animal born diseases)
 Fire risks
 Commonly seen in single persons with social anxiety
or dependent personality traits
 Seen in dementia, CVA, and schizophrenia (slightly
different presentation)
 Begins in early adolescence, often persists over
lifetime
 Most lack insight into their illness (ego-syntonic)
 Treatment
 Medications aren’t effective
 Cognitive behavioral interventions are most effective
http://www.thewowdecor.com/how-to-help-the-
hoarder-in-your-house/
 Trichotillomania coined by a French dermatologist Francois Hallopeau in 1889
 Chronic disorder characterized by repetitive hair pulling
 Results in hair loss
 Increased tension prior to hair pulling and relief of tension or gratification after the hair pulling
 0.6-3.4% lifetime prevalence
 Women:Men = 10:1
 35%-40% chew or swallow the hair
 Bezoars – hairballs in the GI tract  Obstruction
 Pharmacological Treatments
 SSRIs
 SNRIs
 Lithium
 Pimozide
 Naltrexone
 Buspirone
 Clonazepam
 Trazodone
 Behavioral Treatments
 Biofeedback
 Insight-oriented psychotherapy
 Hypnotherapy
https://www.cbc.ca/life/wellness/the-
truth-about-trichotillomania-the-
hair-pulling-disorder-1.3865541
 Compulsive and repetitive picking of the skin
 1-5% lifetime prevalence
 Women>Men
 Rule out stimulant induced excoriation
 Face (most common)
 Also: Legs, Arms, Torso, Hands, Cuticles, Fingers, Scalp
 Embarrassment and avoidance/social withdrawal
 12% of skin-picking patients have attempted suicide
 Pharmacological Treatments
 Fluoxetine
 Naltrexone
 Lamotrigine
 Behavioral Treatments
 Cognitive Behavioral Therapy
 Habit Reversal
 THE END
 Stay tuned for more Simply Psych EDU Lectures!
 www.simplypsychedu.com
1. Afshar, Hamid et al. "N-Acetylcysteine Add-On Treatment in Refractory Obsessive-
Compulsive Disorder." Journal of Clinical Psychopharmacology (2012): 797-803. Print.
2. Pauls, David L., Amitai Abramovitch, Scott L. Rauch, and Daniel A. Geller.
"Obsessive–compulsive Disorder: An Integrative Genetic and Neurobiological
Perspective." Nature Reviews Neuroscience Nat Rev Neurosci (2014): 410-24. Print.
3. Oliver, Georgina, Olivia Dean, David Camfield, Scott Blair-West, Chee Ng, Michael
Berk, and Jerome Sarris. "N-Acetyl Cysteine in the Treatment of Obsessive
Compulsive and Related Disorders: A Systematic Review." Clin Psychopharmacol
Neurosci Clinical Psychopharmacology and Neuroscience (2015): 12-24. Print.
4. "Obsessive Compulsive Disorder." Dynamed.
5. Sadock, Benjamin J., and Harold I. Kaplan. Kaplan & Sadock's Synopsis of
Psychiatry: Behavioral Sciences/clinical Psychiatry. 10th ed. Philadelphia: Wolter
Kluwer/Lippincott Williams & Wilkins, 2007. Print.
6. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington,
D.C.: American Psychiatric Association, 2013. Print.
7. Stahl’s Essential Psychopharmacology, 4th Edition. Cambridge University Press. 2013

More Related Content

PPTX
Obsessive compulsive and related disorders
PDF
Anxiety disorders
PDF
obsessive compulsive and related disorders (OCD)
PPTX
Obsessive-Compulsive and Related Disorders (DSM-V)
PPTX
theory of personality by sigmund freud
PPTX
Obsessive compulsivedisorder
PPT
Obsessive compulsive disorder
PDF
Mental State Examination (MSE)
Obsessive compulsive and related disorders
Anxiety disorders
obsessive compulsive and related disorders (OCD)
Obsessive-Compulsive and Related Disorders (DSM-V)
theory of personality by sigmund freud
Obsessive compulsivedisorder
Obsessive compulsive disorder
Mental State Examination (MSE)

What's hot (20)

PPTX
Ocd overview
PPT
Presentation Ocd
PPTX
Delusion ppt
PPT
Personality disorders
PPTX
Psychopathology of delusion
PPTX
Adjustment disorder
PPTX
Social anxiety disorder
PPTX
Paranoid personality disorder
PPT
Dissociative Disorders
PPT
Elimination disorder - dsm V
PDF
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
 
PPSX
Dissociative disorders
PPTX
Disorders of thought 1
PPTX
PHENOMENOLOGY OF DELUSION
PPT
OBSESSIVE COMPULSIVE DISORDER (OCD)
PPTX
psychosocial intervention for children and adolescents with depression
PPTX
schizotypal personality disorder
PPTX
Disruptive impulse-control and conduct disorders DSM 5
PPTX
Personality disorders
PPTX
Ocd spectrum disorder
Ocd overview
Presentation Ocd
Delusion ppt
Personality disorders
Psychopathology of delusion
Adjustment disorder
Social anxiety disorder
Paranoid personality disorder
Dissociative Disorders
Elimination disorder - dsm V
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
 
Dissociative disorders
Disorders of thought 1
PHENOMENOLOGY OF DELUSION
OBSESSIVE COMPULSIVE DISORDER (OCD)
psychosocial intervention for children and adolescents with depression
schizotypal personality disorder
Disruptive impulse-control and conduct disorders DSM 5
Personality disorders
Ocd spectrum disorder
Ad

Similar to OCD and Related Disorders (20)

PPTX
Oc spectrum disorder
PPTX
obsessivecompulsivedisorder- OCD presentation
DOCX
Running Head PSY 350 WEEK 2 OUTLINE .docx
PPTX
Obsessive Compulsive Disorder (OCD)
PPTX
PPTX
Obsessive compulsive disorder
PPT
PPT
PPTX
Etiology of OCD
PPTX
Obsessive compulsive disorder
PPTX
Ocd in pregnant and postpartum women
PPTX
OBSESSIVE_COMPULISVE_DISORDER_(OCD).pptx
PPTX
Schizophrenia.pptx.jnfdnjdnfjdndfjdnjdnfdjnj
PPTX
Obsessive compulsive disorder
PPTX
Impulse Control Disorders
PPTX
Intellectual disability by dr sunil
PDF
Obsessive Compulsive Disorder | Psychiatric Nursing | Juhin J
PPTX
Obsessive Compulsive Disorder
PPT
Hanipsych, OCD
Oc spectrum disorder
obsessivecompulsivedisorder- OCD presentation
Running Head PSY 350 WEEK 2 OUTLINE .docx
Obsessive Compulsive Disorder (OCD)
Obsessive compulsive disorder
Etiology of OCD
Obsessive compulsive disorder
Ocd in pregnant and postpartum women
OBSESSIVE_COMPULISVE_DISORDER_(OCD).pptx
Schizophrenia.pptx.jnfdnjdnfjdndfjdnjdnfdjnj
Obsessive compulsive disorder
Impulse Control Disorders
Intellectual disability by dr sunil
Obsessive Compulsive Disorder | Psychiatric Nursing | Juhin J
Obsessive Compulsive Disorder
Hanipsych, OCD
Ad

Recently uploaded (20)

PPT
Rheumatology Member of Royal College of Physicians.ppt
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPTX
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
regulatory aspects for Bulk manufacturing
PPTX
Clinical approach and Radiotherapy principles.pptx
PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
PPTX
Morphology of Bacterial Cell for bsc sud
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
PDF
Cardiology Pearls for Primary Care Providers
PPTX
ONCOLOGY Principles of Radiotherapy.pptx
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPTX
2 neonat neotnatology dr hussein neonatologist
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPTX
vertigo topics for undergraduate ,mbbs/md/fcps
PPT
Infections Member of Royal College of Physicians.ppt
Rheumatology Member of Royal College of Physicians.ppt
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
y4d nutrition and diet in pregnancy and postpartum
Cardiovascular - antihypertensive medical backgrounds
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Electrolyte Disturbance in Paediatric - Nitthi.pptx
regulatory aspects for Bulk manufacturing
Clinical approach and Radiotherapy principles.pptx
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
Morphology of Bacterial Cell for bsc sud
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
Cardiology Pearls for Primary Care Providers
ONCOLOGY Principles of Radiotherapy.pptx
شيت_عطا_0000000000000000000000000000.pdf
2 neonat neotnatology dr hussein neonatologist
Acute Coronary Syndrome for Cardiology Conference
vertigo topics for undergraduate ,mbbs/md/fcps
Infections Member of Royal College of Physicians.ppt

OCD and Related Disorders

  • 2.  Introduction to Obsessive Compulsive and Related Disorders  Epidemiology of OCD  Diagnosis of OCD  Neurobiology of Impulsivity and Compulsivity  Treatment  Prognosis  Brief tour of the other OCD spectrum disorders
  • 3. At the conclusion of this lecture, you should be able:  To recognize the signs and symptoms of OCD and related disorders  To review the basic neurobiology of impulsivity and compulsivity  To recall the available treatment options for OCD and related disorders
  • 4.  What is an obsession?  A recurrent and intrusive thought, feeling, idea, or sensation  An obsession is a mental event  What is a compulsion?  A compulsion is a conscious, standardized, recurrent behavior, such as counting, checking, or avoiding  A compulsion is a behavior  In OCD, obsessions and compulsions are ego-dystonic  Compulsive acts are carried out in an attempt to relieve the anxiety associated with the obsession  Sometimes it works, sometimes it doesn’t work  Resisting a compulsive act increases anxiety
  • 5.  Epidemiology  2-3% lifetime prevalence in general population  4th most common outpatient psychiatric diagnosis  10% of outpatients in psychiatric clinics  Epidemiological studies in Europe, Asia, and Africa have confirmed these rates across cultural boundaries  Estimated that 40% of patients do not achieve a clinical response from SSRIs1
  • 6.  Epidemiology (Continued…)  Females slightly more than males in adulthood  Boys 2-3 times more affected than girls in childhood  Mean onset 19.5 years old, rarely onset after 35  Males earlier age of onset than females  Mean age of onset: 20 years  Boys: 19 years (mean)  Girls: 22 years (mean)  ~60% have onset of symptoms before 25yo  <15% have onset of symptoms after 35yo  Single persons > Married persons  Possible Risk Factors  Genetic factors (monozygotic concordance rate of 0.57)  Environmental factors (trauma, abuse, perinatal, infectious)  Psychosocial and developmental factors  Controversy  Childhood streptococcal infections increase risk of OCD (PANDAS)?
  • 7.  Associated conditions  90% of patients with OCD have psychiatric comorbidities  76% Anxiety disorders  63% Mood disorders  56% Impulse control disorders  39% Substance use disorders  30% of patients with OCD have accompanying tic disorder  OCD in children and adolescents  Comorbidities reported in up to 50% pediatric patients  ADHD  Separation anxiety disorder  Specific phobias  Anxiety disorders  Tourette disorder
  • 8.  DSM-5 Criteria A. Presence of obsession, compulsions, or both  Obsessions are defined by 1 and 2 1. Recurrent and persistent thoughts, urges, or images that are experienced, at some time during the disturbance, as intrusive and unwanted, and that cause marked anxiety or distress 2. The individual attempts to ignore or suppress such thoughts, urges, or images, or to neutralize them with some other thought or action (ie., by performing a compulsion)
  • 9.  DSM-5 Criteria A. Presence of obsessions, compulsions, or both  Compulsions are defined by 1 and 2 1. Repetitive behaviors or mental acts that the individual feels driven to perform in response to an obsession or according to rules that must be applied rigidly 2. The behaviors or mental acts are aimed at preventing or reducing anxiety or distress, or preventing some dreaded event or situation; however, these behaviors or mental acts are not connected in a realistic way with what they are designed to neutralize or prevent, or are clearly excessive
  • 10.  DSM-5 Criteria B. The obsessions or compulsions are time-consuming (e.g., take more than 1 hour per day) or cause clinically significant distress or impairment in social, occupational, or other important areas of functioning C. Symptoms are not attributable to the physiological effects of a substance or another medication D. The disturbance is not better explained by symptoms of another mental disorder (e.g., GAD, hoarding do, trichotillomania do, excoriation do, eating do, etc) Specifiers  Insight: good, fair, poor, absent, delusional  Tic-related: The individual has a current or past history of a tic disorder
  • 11. Contamination (hand washing, cleaning) Symmetry/Precision (Slowness) Intrusive Thoughts Pathological Doubt (Checking) There is considerable overlap, but generally patients present with a predominant symptom pattern of an obsession-compulsion pair. Compulsions in parenthesis
  • 12. YBOCS is often used in clinical research in an attempt to quantify OCD symptom severity and track progress over time
  • 13. Pauls, David L., Amitai Abramovitch, Scott L. Rauch, and Daniel A. Geller. "Obsessive–compulsive Disorder: An Integrative Genetic and Neurobiological Perspective." Nature Reviews Neuroscience Nat Rev Neurosci (2014): 410-24. Print.
  • 14.  Neurotransmitters implicated in OCD pathophysiology  Serotonin – supported by alleviation of symptoms with SSRIs  Glutamate – glutamate modulating drugs showing promising results  Dopamine  Cortico-striato-thalamo-cortical circuit (CSTC)  Hyperactivity in orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and caudate nucleus  Glutamate is the primary excitatory neurotransmitter in CSTC  Increased Glutamate levels in CSF, caudate, and OFC in OCD pts
  • 15. Circuitry of impulsivity and reward. The “bottom-up” circuit that drives impulsivity (shown in pink) is a loop with projections from the ventral striatum to the thalamus, from the thalamus to the ventromedial prefrontal cortex (VMPFC), and from the VMPFC back to the ventral striatum. This circuit is usually modulated “top-down” from the prefrontal cortex (PFC). If this top-down response inhibition system is inadequate or is overcome by activity from the bottom-up ventral striatum, impulsive behaviors may result. Circuitry of compulsivity and motor response inhibition. The “bottom-up” circuit that drives compulsivity (shown in pink) is a loop with projections from the dorsal striatum to the thalamus, from the thalamus to the orbitofrontal cortex (OFC), and from the OFC back to the dorsal striatum. This habit circuit can be modulated “top- down” from the OFC, but if this top-down response inhibition system is inadequate or is overcome by activity from the bottom-up dorsal striatum, compulsive behaviors may result. Stahl’s Essential Psychopharmacology 4th ed
  • 16.  Etiology & Pathophysiology – remains unclear  Heterogeneous  Biological Factors  Genetic polymorphisms  Autoimmune processes  Infection  Inflammatory and oxidative stress  Abnormalities of neurotransmission  Behavioral Factors  Psychosocial Factors
  • 17. Pauls, David L., Amitai Abramovitch, Scott L. Rauch, and Daniel A. Geller. "Obsessive–compulsive Disorder: An Integrative Genetic and Neurobiological Perspective." Nature Reviews Neuroscience Nat Rev Neurosci (2014): 410-24. Print.
  • 18. Pauls, David L., Amitai Abramovitch, Scott L. Rauch, and Daniel A. Geller. "Obsessive–compulsive Disorder: An Integrative Genetic and Neurobiological Perspective." Nature Reviews Neuroscience Nat Rev Neurosci (2014): 410-24. Print.
  • 19.  Current Treatment (pharmacotherapy + behavioral)  SSRIs (typically requires higher doses compared to depression)  Fluoxetine  Fluvoxamine  Paroxetine  Sertraline  Citalopram  Clomipramine  TCA most selective for serotonin reuptake  Other therapies  ECT  Surgery (Psychosurgery)  Deep Brain Stimulation  Glutamatergic agents
  • 20.  Problems with current treatment  Only 20-30% of patients have significant improvement  40-50% of patients have moderate improvement  20-40% of patients do not respond or get worse!  Higher doses of SSRIs required to alleviate symptoms in OCD  Associated adverse effects lead to patient non-compliance
  • 21. • Obsessive-Compulsive or Related Disorder Due to another medical condition • PANDAS • Substance induced Obsessive-Compulsive or related disorder • Olfactory Reference Syndrome • Body Dysmorphic Disorder • Hoarding Disorder • Hair-Pulling Disorder (Trichotillomania) • Excoriation (Skin-Picking) Disorder
  • 22. Hypothesis: Acute and rapid onset of OCD/Tics symptoms in a subset of children with group A beta hemolytic streptococcal infections. Antibodies to GABHS cross react with basal ganglia neurons causing dysfunction Controversial https://www.healthynewbornnetwork.org/blog/have- you-got-data-on-follow-up-of-children-after-group-b- streptococcus-infection/
  • 23.  A false belief by the patient that he or she has a foul body odor that is not perceived by others  Leads to excessive showering, changing clothes  May rise to level of somatic delusion  (Delusional Disorder)  Rule out organic illness  Temporal lobe epilepsy  Pituitary tumors  Sinusitis
  • 24.  Preoccupation with an imagined defect in appearance that causes clinically significant distress  If a slight physical anomaly is actually present, the person’s concern with the anomaly is excessive and bothersome  Compulsions:  Mirror checking  Excessive grooming  Comparing appearance to others  Men: preoccupation with muscle mass and “bulking up”  Women>Men; unmarried; AoO = 15-30years  High comorbidity with MDD, Anxiety, Psychosis  Body dysmorphic Disorder more often seen in  Plastic Surgery Clinics  Dermatology Clinics  Internist/Primary Care Clinics  Treatments  Fluoxetine  Clomipramine  TCAs  MAOIs  Psychotherapy  Surgical/procedural interventions rarely benefit these patients https://en.wikipedia.org/wiki/Body_dysmorp hic_disorder
  • 25.  Acquiring and not discarding unimportant possessions of little or no value  Obsessive fear of losing important items that may be needed in the future  Distorted beliefs about the importance of possessions  Excessive emotional attachment to possessions  Leads to  Cluttering  Unsanitary living conditions  Health risks (falls, animal born diseases)  Fire risks  Commonly seen in single persons with social anxiety or dependent personality traits  Seen in dementia, CVA, and schizophrenia (slightly different presentation)  Begins in early adolescence, often persists over lifetime  Most lack insight into their illness (ego-syntonic)  Treatment  Medications aren’t effective  Cognitive behavioral interventions are most effective http://www.thewowdecor.com/how-to-help-the- hoarder-in-your-house/
  • 26.  Trichotillomania coined by a French dermatologist Francois Hallopeau in 1889  Chronic disorder characterized by repetitive hair pulling  Results in hair loss  Increased tension prior to hair pulling and relief of tension or gratification after the hair pulling  0.6-3.4% lifetime prevalence  Women:Men = 10:1  35%-40% chew or swallow the hair  Bezoars – hairballs in the GI tract  Obstruction  Pharmacological Treatments  SSRIs  SNRIs  Lithium  Pimozide  Naltrexone  Buspirone  Clonazepam  Trazodone  Behavioral Treatments  Biofeedback  Insight-oriented psychotherapy  Hypnotherapy https://www.cbc.ca/life/wellness/the- truth-about-trichotillomania-the- hair-pulling-disorder-1.3865541
  • 27.  Compulsive and repetitive picking of the skin  1-5% lifetime prevalence  Women>Men  Rule out stimulant induced excoriation  Face (most common)  Also: Legs, Arms, Torso, Hands, Cuticles, Fingers, Scalp  Embarrassment and avoidance/social withdrawal  12% of skin-picking patients have attempted suicide  Pharmacological Treatments  Fluoxetine  Naltrexone  Lamotrigine  Behavioral Treatments  Cognitive Behavioral Therapy  Habit Reversal
  • 28.  THE END  Stay tuned for more Simply Psych EDU Lectures!  www.simplypsychedu.com
  • 29. 1. Afshar, Hamid et al. "N-Acetylcysteine Add-On Treatment in Refractory Obsessive- Compulsive Disorder." Journal of Clinical Psychopharmacology (2012): 797-803. Print. 2. Pauls, David L., Amitai Abramovitch, Scott L. Rauch, and Daniel A. Geller. "Obsessive–compulsive Disorder: An Integrative Genetic and Neurobiological Perspective." Nature Reviews Neuroscience Nat Rev Neurosci (2014): 410-24. Print. 3. Oliver, Georgina, Olivia Dean, David Camfield, Scott Blair-West, Chee Ng, Michael Berk, and Jerome Sarris. "N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review." Clin Psychopharmacol Neurosci Clinical Psychopharmacology and Neuroscience (2015): 12-24. Print. 4. "Obsessive Compulsive Disorder." Dynamed. 5. Sadock, Benjamin J., and Harold I. Kaplan. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/clinical Psychiatry. 10th ed. Philadelphia: Wolter Kluwer/Lippincott Williams & Wilkins, 2007. Print. 6. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, D.C.: American Psychiatric Association, 2013. Print. 7. Stahl’s Essential Psychopharmacology, 4th Edition. Cambridge University Press. 2013